Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04709900

CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes

DYnamic CT Stress Myocardial perfusioN, CT Fractional Flow Reserve and Coronary CT Angiography for Optimized treatMent Strategy In Patients With sTable Chest Pain syndromEs

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2,000 (estimated)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of the DYNAMITE trial (Dynamic CT stress myocardial perfusion, CT fractional flow reserve (FFR-CT) and coronary CT angiography for optimized treatment strategy in patients with chest pain syndromes) is to determine the ability of combined anatomical and functional cardiac CT imaging to improve morbidity and mortality in patients with suspected or known ischemic heart disease.

Detailed description

Trial design The DYNAMITE trial is an investigator-initiated, randomised controlled, open-labelled trial conducted in the Capital Region of Copenhagen, Denmark The following hypothesis will be tested: * First primary hypothesis: A treatment strategy guided by combined dynamic CT myocardial stress perfusion, FFR-CT and CT coronary angiography improves clinical outcome compared with a conventional management strategy in patients with chronic chest pain syndromes * Second primary hypothesis: A treatment strategy guided by combined dynamic CT stress myocardial perfusion, FFR-CT and CT coronary angiography results in improved symptom relief compared with a conventional management strategy in patients with chronic chest pain syndromes

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCT angiography, FFR-CT and stress CT myocardial perfusionThe study intervention team consists of a specialist in Cardiac CT imaging, an invasive cardiologist, a thoracic surgeon and a cardiology nurse specialist. Treatment strategy defined by the study team based on CT findings involve referral for percutaneous coronary intervention, Coronary Artery Bypass surgery and/or initiation of optimal medical therapy, in addition to potential supplementary diagnostic procedures.

Timeline

Start date
2021-12-03
Primary completion
2024-12-01
Completion
2031-12-01
First posted
2021-01-14
Last updated
2022-12-12

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04709900. Inclusion in this directory is not an endorsement.